Search results
Results from the WOW.Com Content Network
Common side effects include headache, nausea, easy bruising, itching, and heartburn. [10] More severe side effects include bleeding and thrombotic thrombocytopenic purpura. [10] While there is no evidence of harm from use during pregnancy, such use has not been well studied. [3] Clopidogrel is in the thienopyridine-class of antiplatelets. [10]
Some side effects, such as weight gain, occur more frequently with certain types of antidepressant medication. Switching to a new type of antidepressant may help reverse any weight gain you’ve ...
GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the average user. (Reminder that there are many of these meds now. GLP-1s ...
Some studies have found that clopidogrel activity on platelets was hampered significantly by patients receiving treatment with omeprazole, a proton pump inhibitor (PPI). [34] [35] Another study also showed lansoprazole to have hampering effects on clopidogrel activity. [36]
In addition to potentially affecting your appetite, eating habits and weight, Lexapro and similar antidepressants may also cause other side effects. Most potential side effects of Lexapro are mild ...
The most common side effects of these drugs that led to withdrawals were mental disturbances, cardiac side effects, and drug abuse or drug dependence. Deaths were associated with seven products. [84] Ephedra was removed from the US market in 2004 over concerns that it raises blood pressure and could lead to strokes and death. [85]
Side effects range from non-life-threatening GI discomfort to more serious issues like kidney failure, and shortages have made accessing these medications challenging for those who really need them.
The evidence did not identify any difference between the effects of different blood thinners on death, developing a clot, or bleeding. [2] A 2021 review found that low molecular weight heparin (LMWH) was superior to unfractionated heparin in the initial treatment of venous thromboembolism for people with cancer.